CPIG
TCRT icon

Chicago Partners Investment Group’s Alaunos Therapeutics TCRT Stock Holding History

Chicago Partners Investment Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-94
Closed -$2.6K – 755
2023
Q4 		$2.6K Hold
94
– – ﹤0.01% 700
2023
Q3 		$1.54K Hold
94
– – ﹤0.01% 656
2023
Q2 		$6.31K Hold
94
– – ﹤0.01% 683
2023
Q1 		$7.27K Hold
94
– – ﹤0.01% 662
2022
Q4 		$9.71K Hold
94
– – ﹤0.01% 638
2022
Q3 		$16K Hold
94
– – ﹤0.01% 580
2022
Q2 		$16K Hold
94
– – ﹤0.01% 589
2022
Q1 		$7K Buy
+94
New +$12.1K ﹤0.01% 562

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Chicago Partners Investment Group's TCRT Position: Q1 2024 in Review

Chicago Partners Investment Group sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 94 shares — an estimated $2.6K sold.

Chicago Partners Investment Group first reported a position in TCRT in Q1 2022 and held it in 8 quarters. The position peaked at $16K in Q3 2022. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Chicago Partners Investment Group reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Chicago Partners Investment Group sold 94 Alaunos Therapeutics shares in Q1 2024, an estimated $2.6K.
  • Chicago Partners Investment Group first reported a position in Alaunos Therapeutics in Q1 2022 and held it in 8 quarters.
  • Chicago Partners Investment Group's Alaunos Therapeutics position peaked at $16K in Q3 2022.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Chicago Partners Investment Group's 13F filing for Q1 2024, filed 25 Apr 2024.